The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting Programmed Death 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras/p53-Driven Lung Cancer
Authors:
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 14 (6) , 1046-1060
Abstract
No abstract availableKeywords
Funding Information
- AbbVie
- National Cancer Institute (CA-16359, P50CA196530, R01-CA126801)
- Shire
- Merck Company Foundation
- Exelixis
- Bristol-Myers Squibb
- Takeda Pharmaceuticals North America
- Spectrum Pharmaceuticals
- Novartis
- Sanofi
- Johnson & Johnson Innovative Medicine
- Yale Cancer Center
- Eli Lilly and Company
- Clovis Oncology
- Pfizer
- Yale SPORE in Lung Cancer
This publication has 47 references indexed in Scilit:
- Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 studyThe Lancet Oncology, 2013
- The immunosuppressive tumour network: myeloid‐derived suppressor cells, regulatory T cells and natural killer T cellsImmunology, 2012
- Coordinated regulation of myeloid cells by tumoursNature Reviews Immunology, 2012
- A Phase II, Open-Label, Randomized Study to Assess the Efficacy and Safety of AZD6244 (ARRY-142886) Versus Pemetrexed in Patients with Non-small Cell Lung Cancer Who Have Failed One or Two Prior Chemotherapeutic RegimensJournal of Thoracic Oncology, 2010
- The biology of myeloid‐derived suppressor cells: The blessing and the curse of morphological and functional heterogeneityEuropean Journal of Immunology, 2010
- Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinaseNature Protocols, 2009
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- The Terminology Issue for Myeloid-Derived Suppressor CellsCancer Research, 2007
- K-ras activation generates an inflammatory response in lung tumorsOncogene, 2005
- Role Of Immature Myeloid Cells in Mechanisms of Immune Evasion In CancerCancer Immunology, Immunotherapy, 2005